These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 440805)

  • 1. Kawasaki disease: effect of treatment on coronary artery involvement.
    Kato H; Koike S; Yokoyama T
    Pediatrics; 1979 Feb; 63(2):175-9. PubMed ID: 440805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial.
    Kobayashi T; Saji T; Otani T; Takeuchi K; Nakamura T; Arakawa H; Kato T; Hara T; Hamaoka K; Ogawa S; Miura M; Nomura Y; Fuse S; Ichida F; Seki M; Fukazawa R; Ogawa C; Furuno K; Tokunaga H; Takatsuki S; Hara S; Morikawa A;
    Lancet; 2012 Apr; 379(9826):1613-20. PubMed ID: 22405251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of Kawasaki disease in the acute phase: steroid and aspirin therapy].
    Kato H; Ichinose E
    Nihon Rinsho; 1983 Sep; 41(9):2092-6. PubMed ID: 6663745
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation of treatment and management of Kawasaki coronary artery disease based on clinical severity classification].
    Liu F; Zhao L; Wu L; Liang X; Chu C; He L; Huang G
    Zhonghua Er Ke Za Zhi; 2015 Sep; 53(9):690-5. PubMed ID: 26757970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of warfarin plus aspirin combination therapy for giant coronary artery aneurysm secondary to Kawasaki disease: a meta-analysis.
    Su D; Wang K; Qin S; Pang Y
    Cardiology; 2014; 129(1):55-64. PubMed ID: 25116427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of severe complicated Kawasaki disease with oral prednisolone and aspirin.
    Dale RC; Saleem MA; Daw S; Dillon MJ
    J Pediatr; 2000 Nov; 137(5):723-6. PubMed ID: 11060542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children.
    Wooditch AC; Aronoff SC
    Pediatrics; 2005 Oct; 116(4):989-95. PubMed ID: 16199713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Kawasaki disease: new and important problems in cardiology].
    Kato H; Ichinose E
    J Cardiogr; 1983 Sep; 13(3):731-47. PubMed ID: 6678300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A trial procedure to prevent aneurysm formation of the coronary arteries by steroid pulse therapy in Kawasaki disease.
    Kijima Y; Kamiya T; Suzuki A; Hirose O; Manabe H
    Jpn Circ J; 1982 Nov; 46(11):1239-42. PubMed ID: 7131714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fate of coronary aneurysms in Kawasaki disease: serial coronary angiography and long-term follow-up study.
    Kato H; Ichinose E; Yoshioka F; Takechi T; Matsunaga S; Suzuki K; Rikitake N
    Am J Cardiol; 1982 May; 49(7):1758-66. PubMed ID: 7081062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathologic and coronary angiographic assessment of effectiveness of aspirin or aspirin-and-gammaglobulin in Kawasaki disease.
    Haneda N; Mori C
    Acta Paediatr Jpn; 1993 Aug; 35(4):294-7. PubMed ID: 7691025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The mucocutaneous lymph node syndrome (Kawasaki syndrome). A case with gallbladder hydrops and coronary artery aneurysm].
    Fritz ME; Giambonini S; Jenni R; D'Apuzzo V
    Schweiz Med Wochenschr; 1981 Apr; 111(16):566-71. PubMed ID: 7233135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of thrombosis of coronary aneurysms in patients with a history of Kawasaki disease].
    Suda K; Kudo Y; Sugawara Y; Ishii M; Matsuishi T
    Nihon Rinsho; 2008 Feb; 66(2):355-9. PubMed ID: 18265459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aneurysms of the coronary arteries in Kawasaki disease. An angiographic study of 30 cases.
    Onouchi Z; Shimazu S; Kiyosawa N; Takamatsu T; Hamaoka K
    Circulation; 1982 Jul; 66(1):6-13. PubMed ID: 7083521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guideline-Concordant Treatment of Kawasaki Disease With Immunoglobulin and Aspirin and the Incidence of Coronary Artery Aneurysm.
    Michihata N; Matsui H; Fushimi K; Yasunaga H
    Clin Pediatr (Phila); 2015 Oct; 54(11):1076-80. PubMed ID: 25573948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kawasaki disease: part II. Complications and treatment.
    Bayers S; Shulman ST; Paller AS
    J Am Acad Dermatol; 2013 Oct; 69(4):513.e1-8; quiz 521-2. PubMed ID: 24034380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term changes in coronary artery aneurysms in patients with Kawasaki disease: comparison of therapeutic regimens.
    Onouchi Z; Hamaoka K; Sakata K; Ozawa S; Shiraishi I; Itoi T; Kiyosawa N
    Circ J; 2005 Mar; 69(3):265-72. PubMed ID: 15731529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacies and risks of aspirin in the treatment of the Kawasaki disease.
    Kusakawa S; Tatara K
    Prog Clin Biol Res; 1987; 250():401-13. PubMed ID: 3423052
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
    Hsieh KS; Weng KP; Lin CC; Huang TC; Lee CL; Huang SM
    Pediatrics; 2004 Dec; 114(6):e689-93. PubMed ID: 15545617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute myocardial infarction as the first manifestation of the incomplete Kawasaki disease in a young male.
    Javadzadegan H; Mehdizadeh Baghbani J; Farhang S
    Cardiol Young; 2009 Dec; 19(6):635-7. PubMed ID: 19737437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.